$SLXP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SALIX PHARMACEUTICALS LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SALIX PHARMACEUTICALS LTD. Get notifications about new insider transactions in SALIX PHARMACEUTICALS LTD for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 8 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.01 | 1,000 | 12,010 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 76,000 | |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 77,000 | |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 78,000 | |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.85 | 221 | 2,840 | 108,371 | 108.6 K to 108.4 K (-0.20 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.84 | 700 | 8,988 | 108,592 | 109.3 K to 108.6 K (-0.64 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.80 | 79 | 1,011 | 109,292 | 109.4 K to 109.3 K (-0.07 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.70 | 1,000 | 12,700 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.95 | 1,000 | 12,950 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 73,000 | |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 74,000 | |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 75,000 | |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.64 | 100 | 1,264 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.62 | 100 | 1,262 | 108,471 | 108.6 K to 108.5 K (-0.09 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.60 | 200 | 2,520 | 108,571 | 108.8 K to 108.6 K (-0.18 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.58 | 600 | 7,548 | 108,771 | 109.4 K to 108.8 K (-0.55 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.50 | 1,000 | 12,500 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.88 | 1,000 | 12,880 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 79,000 | |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 80,000 | |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 81,000 | |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.62 | 1,000 | 12,620 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.89 | 1,000 | 12,890 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.70 | 1,000 | 12,700 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 20 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 10,921 | 141,755 | 3,719,829 | 3.7 M to 3.7 M (-0.29 %) |
| Aug 20 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.96 | 70,000 | 907,200 | 3,730,750 | 3.8 M to 3.7 M (-1.84 %) |
| Aug 18 2009 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Sell | S | 12.57 | 5,200 | 65,364 | 54,244 | 59.4 K to 54.2 K (-8.75 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 82,000 | |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 83,000 | |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 84,000 | |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.72 | 1,000 | 12,720 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.38 | 1,000 | 12,380 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.35 | 1,000 | 12,350 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 17 2009 | SLXP | SALIX PHARMACEUTIC ... | Sirgo Mark A | Director | Buy | P | 12.50 | 250 | 3,125 | 36,306 | 36.1 K to 36.3 K (+0.69 %) |
| Aug 17 2009 | SLXP | SALIX PHARMACEUTIC ... | Sirgo Mark A | Director | Buy | P | 12.49 | 250 | 3,123 | 36,056 | 35.8 K to 36.1 K (+0.70 %) |
| Aug 17 2009 | SLXP | SALIX PHARMACEUTIC ... | Sirgo Mark A | Director | Buy | P | 12.45 | 250 | 3,113 | 35,806 | 35.6 K to 35.8 K (+0.70 %) |
| Aug 17 2009 | SLXP | SALIX PHARMACEUTIC ... | Sirgo Mark A | Director | Buy | P | 12.40 | 200 | 2,480 | 35,556 | 35.4 K to 35.6 K (+0.57 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 85,000 | |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 86,000 | |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 87,000 | |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.66 | 1,000 | 12,660 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.57 | 400 | 5,028 | 108,371 | 108.8 K to 108.4 K (-0.37 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.56 | 600 | 7,536 | 108,771 | 109.4 K to 108.8 K (-0.55 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.59 | 1,000 | 12,590 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 91,000 | |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 92,000 | |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 93,000 | |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.51 | 1,000 | 12,510 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.33 | 1,000 | 12,330 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.10 | 1,000 | 12,100 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 88,000 | |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 89,000 | |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 90,000 | |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.60 | 1,000 | 12,600 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.49 | 1,000 | 12,490 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.33 | 1,000 | 12,330 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 94,000 | |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 95,000 | |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 96,000 | |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.22 | 1,000 | 12,220 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.27 | 1,000 | 12,270 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.67 | 1,000 | 12,670 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 97,000 | |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 98,000 | |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 99,000 | |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.76 | 1,000 | 12,760 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.99 | 1,000 | 12,990 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.55 | 1,000 | 12,550 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | S | 12.55 | 14,852 | 186,393 | 3,800,750 | 3.8 M to 3.8 M (+0.39 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.55 | 9,901 | 124,258 | 2,176,124 | 2.2 M to 2.2 M (-0.45 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | S | 12.98 | 113,182 | 1,469,102 | 3,815,602 | 3.7 M to 3.8 M (+3.06 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 75,448 | 979,315 | 2,186,025 | 2.3 M to 2.2 M (-3.34 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.11 | 86,540 | 1,134,539 | 3,928,784 | 4 M to 3.9 M (-2.16 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.11 | 57,689 | 756,303 | 2,261,473 | 2.3 M to 2.3 M (-2.49 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 100,000 | |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 101,000 | |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 102,000 | |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.17 | 100 | 1,217 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.19 | 200 | 2,438 | 108,471 | 108.7 K to 108.5 K (-0.18 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.22 | 100 | 1,222 | 108,671 | 108.8 K to 108.7 K (-0.09 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.29 | 25 | 307 | 108,771 | 108.8 K to 108.8 K (-0.02 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.38 | 175 | 2,167 | 108,796 | 109 K to 108.8 K (-0.16 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.41 | 400 | 4,964 | 108,971 | 109.4 K to 109 K (-0.37 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.75 | 100 | 1,175 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.76 | 300 | 3,528 | 108,471 | 108.8 K to 108.5 K (-0.28 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.78 | 200 | 2,356 | 108,771 | 109 K to 108.8 K (-0.18 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.80 | 100 | 1,180 | 108,971 | 109.1 K to 109 K (-0.09 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.81 | 100 | 1,181 | 109,071 | 109.2 K to 109.1 K (-0.09 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.82 | 200 | 2,364 | 109,171 | 109.4 K to 109.2 K (-0.18 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.31 | 270 | 3,054 | 108,371 | 108.6 K to 108.4 K (-0.25 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.34 | 30 | 340 | 108,641 | 108.7 K to 108.6 K (-0.03 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.35 | 100 | 1,135 | 108,671 | 108.8 K to 108.7 K (-0.09 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.37 | 300 | 3,411 | 108,771 | 109.1 K to 108.8 K (-0.28 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.38 | 200 | 2,276 | 109,071 | 109.3 K to 109.1 K (-0.18 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.41 | 100 | 1,141 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
| Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 103,000 | |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 104,000 | |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 105,000 | |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.00 | 175 | 1,925 | 108,371 | 108.5 K to 108.4 K (-0.16 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.02 | 25 | 276 | 108,546 | 108.6 K to 108.5 K (-0.02 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.03 | 200 | 2,206 | 108,571 | 108.8 K to 108.6 K (-0.18 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.04 | 300 | 3,312 | 108,771 | 109.1 K to 108.8 K (-0.28 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.05 | 200 | 2,210 | 109,071 | 109.3 K to 109.1 K (-0.18 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.06 | 100 | 1,106 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.97 | 100 | 1,097 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.01 | 100 | 1,101 | 108,471 | 108.6 K to 108.5 K (-0.09 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.02 | 400 | 4,408 | 108,571 | 109 K to 108.6 K (-0.37 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.03 | 300 | 3,309 | 108,971 | 109.3 K to 109 K (-0.27 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.06 | 100 | 1,106 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.68 | 300 | 3,204 | 108,371 | 108.7 K to 108.4 K (-0.28 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.70 | 100 | 1,070 | 108,671 | 108.8 K to 108.7 K (-0.09 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.81 | 300 | 3,243 | 108,771 | 109.1 K to 108.8 K (-0.28 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.83 | 100 | 1,083 | 109,071 | 109.2 K to 109.1 K (-0.09 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.86 | 100 | 1,086 | 109,171 | 109.3 K to 109.2 K (-0.09 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.87 | 100 | 1,087 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
| Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |